Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$40.16
-1.99%
Mkt Cap $2.37B
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (10 analysts)
$57.60
Range $40.00 – $65.00
Implied Upside
+43.4%
Consensus $57.60 vs current $40.16